Compare, Analyse Biocon with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ACTAVIS (US) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ACTAVIS
EQUITY SHARE DATA
    BIOCON
Mar-19
ACTAVIS
Dec-18
BIOCON /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs70714,247-   
Low Rs5549,557-   
Sales per share (Unadj.) Rs91.93,494.9-  
Earnings per share (Unadj.) Rs16.7-1,125.7-  
Cash flow per share (Unadj.) Rs24.2368.3-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.614,414.7-  
Shares outstanding (eoy) m600.00332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.93.4 201.5%   
Avg P/E ratio x37.7-10.6 -356.9%  
P/CF ratio (eoy) x26.132.3 80.7%  
Price / Book Value ratio x6.20.8 751.4%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,3303,958,701 9.6%   
No. of employees `0006.116.9 36.3%   
Total wages/salary Rs m11,6530-   
Avg. sales/employee Rs Th8,994.368,780.9 13.1%   
Avg. wages/employee Rs Th1,900.70-   
Avg. net profit/employee Rs Th1,635.3-22,154.4 -7.4%   
INCOME DATA
Net Sales Rs m55,1441,162,397 4.7%  
Other income Rs m1,44422,229 6.5%   
Total revenues Rs m56,5881,184,626 4.8%   
Gross profit Rs m15,88330,461 52.1%  
Depreciation Rs m4,478496,899 0.9%   
Interest Rs m70967,077 1.1%   
Profit before tax Rs m12,140-511,287 -2.4%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,399 0.0%   
Tax Rs m2,123-6,479 -32.8%   
Profit after tax Rs m10,026-374,409 -2.7%  
Gross profit margin %28.82.6 1,099.1%  
Effective tax rate %17.51.3 1,379.9%   
Net profit margin %18.2-32.2 -56.4%  
BALANCE SHEET DATA
Current assets Rs m48,228476,754 10.1%   
Current liabilities Rs m30,376421,753 7.2%   
Net working cap to sales %32.44.7 684.2%  
Current ratio x1.61.1 140.5%  
Inventory Days Days6820 348.7%  
Debtors Days Days8666 128.9%  
Net fixed assets Rs m64,130131,577 48.7%   
Share capital Rs m3,0000-   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,9804,794,344 1.3%   
Long term debt Rs m15,7661,688,262 0.9%   
Total assets Rs m121,9247,494,650 1.6%  
Interest coverage x18.1-6.6 -273.7%   
Debt to equity ratio x0.30.4 73.4%  
Sales to assets ratio x0.50.2 291.6%   
Return on assets %8.8-4.1 -214.7%  
Return on equity %16.4-7.8 -210.5%  
Return on capital %16.8-4.8 -346.1%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,546415,281 2.8%  
From Investments Rs m-7,138228,143 -3.1%  
From Financial Activity Rs m-2,417-712,746 0.3%  
Net Cashflow Rs m2,103-68,977 -3.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.63 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: NATCO PHARMA  SANOFI INDIA  DISHMAN PHARMA  ABBOTT INDIA  STRIDES PHARMA SCIENCE  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


May 7, 2021 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON - SUN PHARMA COMPARISON

COMPARE BIOCON WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS